Prof Montalescot reviews his study comparing ticagrelor at first medical contact vs cath lab administration in patients undergoing primary PCI.

What do we know about enterovirus D68? Where did it come from, and what can be done about it?

Among Dr Goldhaber's highlights are better risk stratification and the inclusion of the novel oral anticoagulants.

If your facility hasn't adopted the third-edition bundles from the Surviving Sepsis Campaign, here are the details you need.

What are the pros and cons of using thrombolytics in PE patients?

Hans-Christoph Diener comments on 2 important new studies demonstrating that a significant proportion of patients with cryptogenic stroke have a treatable risk factor.

Antipsychotic side effects result in a high rate of ED visits. Find out which drug is the worst offender.

Dr. Hans-Christoph Diener looks at results presented at the 2014 European Stroke Conference – have we "reached a ceiling of clinical benefit"?

More cases of MERS-CoV in the United States are inevitable. Here's what you should look for, and what to do if you suspect MERS-CoV.

We live in a 'global sea of measles,' says Paul A. Offit, MD. The increase in outbreaks relates to overseas travel and the unvaccinated.